Prot #CQBW251X2101: A Randomized, Double Blind Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of Single and Multiple Ascending Doses of QBW251 in Healthy Subjects and Multiple Doses in Cysti

Project: Research project

Project Details

StatusFinished
Effective start/end date8/14/149/30/17

Funding

  • Novartis Pharmaceuticals Corporation (Prot #CQBW251X2101)